
Mabwell's Novel Nectin-4 Targeting ADC 9MW2821 Approved for 2 Clinical Trials by CDE of NMPA
SHANGHAI,Nov. 14,2024-- Mabwell (688062.SH),an innovative biopharmaceutical company with entire industry chain,announced that its novel Nectin-4 targeting ADC (R&D code: 9MW2821) has received IND